GLP-1 agonist medications like tirzepatide work by providing higher concentrations of GLP-1 for longer periods of time, which is thought to increase weight loss
As the dosage reaches its therapeutic level, the effects on weight loss become more pronounced
The most prominent growth trend involves the transition from reliance on injectables for GLP-1 treatment towards oral agents that may increase patient convenience as well as help address issues associated with injection fatigue
I did my research and understood how expertly trained Terri was and how many years of experience she had in training individuals like myself
Whilst improved insulin sensitivity generally has favourable hormonal effects, rapid weight loss can temporarily disrupt hormone levels, including sex hormones and cortisol
Wegovy is specifically FDA-approved for chronic weight management in adults and adolescents aged 12 years and older with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (e.g., hypertension, type 2 diabetes, dyslipidemia) [8] [9]